Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06392295
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-04-25
Brief Title:
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
Sponsor:
University of Miami
Organization:
University of Miami
Study Overview
Official Title:
A Phase II Trial of PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer - The OCEAN Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OCEAN
Brief Summary:
The purpose of this prostate cancer research study is to learn about
1 Improving control of prostate cancer using radiation therapy delivered to the para-aortic and pelvic lymph nodes in addition to systemic androgen suppression therapy
2 Preserving quality of life after radiation therapy
3 Leveraging imaging results from prostate-specific membrane antigen PSMA positron emission tomography PETcomputed tomography CT scans to evaluate and manage disease progression
1 Improving control of prostate cancer using radiation therapy delivered to the para-aortic and pelvic lymph nodes in addition to systemic androgen suppression therapy
2 Preserving quality of life after radiation therapy
3 Leveraging imaging results from prostate-specific membrane antigen PSMA positron emission tomography PETcomputed tomography CT scans to evaluate and manage disease progression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None